Open AccessLYAR promotes the proliferation of non-small cell lung cancer and is associated with poor prognosis
Author(s) -
Xiaoning Lu,
Guanjun Ju,
Yuxin Wang,
Yongliang Wang,
Kun Wang,
Jianle Chen,
Wei Cai,
Qi-Wei Zang
Publication year - 2021
Publication title -
folia histochemica et cytobiologica
Language(s) - English
Resource type - Journals
eISSN - 1897-5631
pISSN - 0239-8508
DOI - 10.5603/fhc.a2021.0030
Subject(s) - cell cycle , cell growth , cancer research , apoptosis , proliferating cell nuclear antigen , flow cytometry , tunel assay , terminal deoxynucleotidyl transferase , immunohistochemistry , lung cancer , biology , cyclin d1 , gene knockdown , pathology , medicine , microbiology and biotechnology , immunology , biochemistry , genetics
The aim of the study was to investigate the clinical significance of Ly-1 antibody reactive clone (LYAR) in non-small-cell lung cancer (NSCLC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom